For the 160 million Americans who get health insurance through their jobs, a stark reality has been building for decades. Between 1999 and 2024, family premiums for employer-sponsored coverage climbed 342%. Workers’ contributions to those premiums rose 308%. Their actual earnings? Up just 119%.
That’s not a gap. That’s a chasm, and it’s widening every year.
A new economic analysis in JAMA Network Open documents what millions of families already know from their paychecks: health coverage is eating an ever-larger slice of what they earn. For many households, the premium deduction hits before they’ve paid for groceries or rent. The numbers suggest something fundamental has broken in how we pay for medical care.
Hospital Prices Drive the Spiral
The researchers zeroed in on one primary driver: hospital costs. Using Consumer Price Index data, they tracked how different components of medical care changed over time. Hospital services showed the sharpest increase, with the index reaching 193 by 2024 compared to 100 in 2006.
What makes this particularly frustrating is that hospital admissions have actually declined. We’re not hospitalized more often. We’re just charged exponentially more each time we are. The authors make the connection explicit:
This economic evaluation found that insurance premiums have increased at 3 times the rate of workers’ earnings since 1999, accompanied by escalating hospital prices.
It’s a dynamic that feels almost parasitic. As hospital bills climb, insurers pass those costs to employers, who pass them to workers through higher premiums and deductibles. The system feeds on itself.
The Drug Price Puzzle
Prescription drugs showed a more complicated pattern. The overall drug price index rose more gradually than hospital costs. But averages can mislead. The CPI weights medications by their share of total pharmacy revenue, which might undercount the financial strain on people managing diabetes, cancer, or other chronic conditions.
The CPI prescription drug measure tracks retail-level price changes of medications as experienced by consumers, specifically transaction prices received by pharmacies.
Some specialty drugs have seen price hikes approaching 300% since launch. Those extremes vanish in the aggregate data, but they’re devastatingly real for the patients who need them.
Health insurance prices themselves spiked during COVID-19 before stabilizing, a reflection of pandemic disruptions and temporarily higher insurer profits as people delayed care. That volatility has since corrected, but the underlying problem remains: a quarter century of health costs growing three times faster than the wages meant to cover them. Something’s got to give.
JAMA Network Open: 10.1001/jamanetworkopen.2025.47462
If our reporting has informed or inspired you, please consider making a donation. Every contribution, no matter the size, empowers us to continue delivering accurate, engaging, and trustworthy science and medical news. Independent journalism requires time, effort, and resources—your support ensures we can keep uncovering the stories that matter most to you.
Join us in making knowledge accessible and impactful. Thank you for standing with us!










